Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Polly Roy

Showing results (121-130 of 125) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 125 results.
Plos One|November 3, 2011
Characterization of protection afforded by a bivalent virus-like particle vaccine against bluetongue virus serotypes 1 and 4 in sheepAna Cristina Pérez de Diego, Thimmasandra N Athmaram, Meredith Stewart, et al.
Journal of Virology|July 29, 2011
Generation of replication-defective virus-based vaccines that confer full protection in sheep against virulent bluetongue virus challengeEiko Matsuo, Cristina C P Celma, Mark Boyce, et al.
Nature|June 24, 2003
Viral infection switches non-plasmacytoid dendritic cells into high interferon producersSandra S Diebold, Maria Montoya, Hermann Unger, et al.
Journal of Virology|November 1, 2016
Replication-Deficient Particles: New Insights into the Next Generation of Bluetongue Virus VaccinesCristina C Celma, Meredith Stewart, Kerstin Wernike, et al.
Journal of Virology|March 23, 2012
The double-stranded RNA bluetongue virus induces type I interferon in plasmacytoid dendritic cells via a MYD88-dependent TLR7/8-independent signaling pathwaySuzana Ruscanu, Florentina Pascale, Mickael Bourge, et al.
Pageof 13

Showing results (121-130 of 125) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 125 results.
Plos One|November 3, 2011
Characterization of protection afforded by a bivalent virus-like particle vaccine against bluetongue virus serotypes 1 and 4 in sheepAna Cristina Pérez de Diego, Thimmasandra N Athmaram, Meredith Stewart, et al.
Journal of Virology|July 29, 2011
Generation of replication-defective virus-based vaccines that confer full protection in sheep against virulent bluetongue virus challengeEiko Matsuo, Cristina C P Celma, Mark Boyce, et al.
Nature|June 24, 2003
Viral infection switches non-plasmacytoid dendritic cells into high interferon producersSandra S Diebold, Maria Montoya, Hermann Unger, et al.
Journal of Virology|November 1, 2016
Replication-Deficient Particles: New Insights into the Next Generation of Bluetongue Virus VaccinesCristina C Celma, Meredith Stewart, Kerstin Wernike, et al.
Journal of Virology|March 23, 2012
The double-stranded RNA bluetongue virus induces type I interferon in plasmacytoid dendritic cells via a MYD88-dependent TLR7/8-independent signaling pathwaySuzana Ruscanu, Florentina Pascale, Mickael Bourge, et al.
Pageof 13